Table 1. Baseline characteristics of women included in the study group (n = 81) and viremic group (n = 16).
Study group | Viremic group | ||
(n = 81) | (n = 16) | ||
Age, years | 40 | 35,5 | |
[35]-[50] | [30]-[50] | ||
Ethnicity, n (%) | |||
Sub-Saharan African | 58 (72) | 12 (75) | |
European | 19 | 4 | |
Other | 4 | 0 | |
Heterosexual HIV transmission, n (%) | 74 (91) | 16 (100) | |
CDC staging, n | |||
A | 49 | 12 | |
B | 16 | 2 | |
C | 16 | 2 | |
Co-infection, n | |||
none | 68 | 14 | |
HBV | 6 | 2 | |
HCV | 7 | 0 | |
Lowest CD4+ T cell count, /µL | 230 | 303 | |
[147-305] | [116-423] | ||
Highest plasma HIV-RNA, log/mL | 5.1 | 4.8 | |
[4.6-5.6] | [3.9-5.7] | ||
Plasma HIV-RNA, log/mL | <1.7 | 3.7 | |
[3.3-4.8] | |||
Vaginal HIV-RNA, log/mL | <1.6 | 2.2 | |
[<1.6-2.4] | |||
HIV-DNA in blood, log/106 PBMCs | 2.7 | 2.8 | |
[2.4-3.1] | [2.4-3.1] | ||
HIV-DNA in vagina, cp/106 cells | 0 | 0 | |
[0-6] | [0-11] | ||
CD4+ T cell count, /µL | 663 | 499 | |
[467-889] | [316-627] | ||
% CD4+ T cells | 33 | 24 | |
[27]-[40] | [18]-[36] | ||
CD4+/CD8+ ratio | 0.9 | 0.5 | |
[0.6-1.3] | [0.3-0.9] | ||
Vaginal colonization, n (%) | 24 (30) | 11 (69) | |
median [IQR] |